Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia

Area of Science:

• Hematopathology
• Immunology
• Oncology

Background:

• B cell chronic lymphocytic leukemia (B-CLL) is a common lymphoid malignancy.
• ZAP-70 expression is an established prognostic marker in B-CLL, differentiating mutated from unmutated disease.
• Accurate and accessible detection of ZAP-70 is crucial for patient stratification and treatment decisions.

Purpose of the Study:

• To establish and validate a straightforward immunohistochemical protocol for ZAP-70 detection in B-CLL tumor cells.
• To assess the clinical relevance of ZAP-70 expression as a prognostic indicator in B-CLL.
• To demonstrate the utility of this method in routine hematopathology laboratories.

Main Methods:

• Bone marrow trephine biopsies from 62 B-CLL patients were analyzed.
• Immunohistochemistry utilizing peroxidase and alkaline phosphatase reactions was employed for ZAP-70 detection.
• Double immunofluorescent labeling was used as a complementary technique.
• Statistical analysis (chi-squared test) correlated ZAP-70 positivity with clinical and cytogenetic prognostic factors.

Main Results:

• ZAP-70 expression was detected in 13 out of 62 B-CLL patients.
• A statistically significant association was found between ZAP-70 positivity and known indicators of a worse prognosis.
• The immunohistochemical method proved effective in identifying ZAP-70 positive cases.

Conclusions:

• Immunohistochemical detection of ZAP-70 is an easy, reliable, and applicable technique for B-CLL diagnosis and prognostication.
• This method, supported by immunofluorescence, aids in identifying patients with a poorer prognosis.
• The protocol is suitable for implementation in standard hematopathology laboratories.